Worldwide Immunoglobulin Industry to 2028 – Prevalence of Immunodeficiency Diseases and Autoimmune Disorders is Driving Growth – ResearchAndMarkets.com

Worldwide Immunoglobulin Industry to 2028 – Prevalence of Immunodeficiency Diseases and Autoimmune Disorders is Driving Growth – ResearchAndMarkets.com




Worldwide Immunoglobulin Industry to 2028 – Prevalence of Immunodeficiency Diseases and Autoimmune Disorders is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Immunoglobulin Market 2022-2028” report has been added to ResearchAndMarkets.com’s offering.

This report suggests that the global immunoglobulin market would exhibit an uptrend trend at a CAGR of 6.77% over the forecast period of 2022-2028.

The market’s growth is supported by driving forces like the increase in the global geriatric population, increasing incidence of age-related diseases, the prevalence of autoimmune disorders, increase in research & development activities and prevalence of immunodeficiency diseases. In contrast, the high price associated with immunoglobulin therapy and the high risk of side effects due to its use are the factors that can challenge the market’s growth.

On the other hand, the increasing adoption of intravenous immunoglobulin (IVIG) treatments and the rising number of clinical trials being conducted indicate an overall positive outlook for the immunoglobulin market.

Regional Outlook

The immunoglobulin market covers North America, the Asia-Pacific, Europe, Latin America, the Middle East, and Africa.

North America is the global leader in the immunoglobulin market and is expected to continue its dominance until the end of the forecast period. The region is home to top companies like Pfizer Inc, CSL Behring, ADMA Biologics, and others, which supports the market’s growth.

In addition, due to the increased incidence of various diseases in the United States and Canada, the immunoglobulin market presents an opportunity for increased use of immunoglobulin. Further, it is anticipated that an increase in product approvals by the US Food and Drug Administration will increase the demand for and adoption of immunoglobulin products in the region.

Competitive Outlook

The key players listed in the global immunoglobulin market include Pfizer Inc, Bio Products Laboratory, Grifols SA, Octapharma AG, China Biologic Products Inc, ADMA Biologics, Sichuan Yuanda Shuyang Pharmaceutical Co Ltd, CSL Behring, Kedrion Biopharma, Kamada Ltd, LFB Group, Sanquin Plasma Products BV, Shanghai RAAS Blood Products Co Ltd, Takeda Pharmaceutical Company Limited, and Biotest AG.

Biotest AG is a globally renowned company that supplies plasma protein products and biotherapeutic medications. Its products are primarily utilized in hematology, clinical immunology, and acute care medicine. The company’s value chain ranges from pre-clinical & clinical development to marketing and distribution. Biotest AG produces albumins, clotting factors, and immunoglobulins obtained from human blood plasma. The business was established in 1946 and currently markets its product in more than 90 nations around the globe. Biotest AG sells its goods directly through its own subsidiaries or with regional distributors and marketing partners.

Key Topics Covered:

1. Global Immunoglobulin Market – Summary

2. Industry Outlook

2.1. Impact of Covid-19 on the Immunoglobulin Market

2.2. Key Insights

2.2.1. Development of New Purification Methods

2.2.2. Increasing Preference for Personalized Medicines

2.3. Porter’s Five Forces Analysis

2.4. Market Attractiveness Index

2.5. Vendor Scorecard

2.6. Key Market Strategies

2.6.1. Product Launches & Developments

2.6.2. Partnerships & Agreements

2.7. Market Drivers

2.7.1. Growth in the Geriatric Population

2.7.2. Prevalence of Immunodeficiency Diseases and Autoimmune Disorders

2.7.3. Increasing Research and Development Activities

2.8. Market Challenges

2.8.1. High Cost of Therapy

2.8.2. High Risk of Side Effects Due to the Use of Immunoglobulin

2.9. Market Opportunities

2.9.1. Increasing Adoption of Intravenous Immunoglobulin (Ivig) Treatments

2.9.2. Growing Clinical Trials

3. Global Immunoglobulin Market Outlook – by Type

3.1. Igg

3.2. Iga

3.3. Igm

3.4. Ige

3.5. Igd

4. Global Immunoglobulin Market Outlook – by Delivery Mode

4.1. Intravenous

4.2. Subcutaneous

4.3. Intramuscular

5. Global Immunoglobulin Market Outlook – by Application

5.1. Hypogamma Globulinemia

5.2. Chronic Inflammatory Demyelinating Polyneuropathy

5.3. Primary Immunodeficiency Diseases

5.4. Myasthenia Gravis

5.5. Multifocal Motor Neuropathy

5.6. Idiopathic Thrombocytopenic Purpura (Itp)

5.7. Inflammatory Myopathies

5.8. Specific Antibody Deficiency

5.9. Guillain-Barre Syndrome

5.10. Other Applications

6. Global Immunoglobulin Market Outlook – by End-User

6.1. Hospitals & Clinics

6.2. Homecare

7. Global Immunoglobulin Market Outlook – by Sales Channel

7.1. Hospital Pharmacy

7.2. Specialty Pharmacy

7.3. Other Sales Channels

8. Global Immunoglobulin Market – Regional Outlook

9. Competitive Landscape

9.1. Biotest AG

9.2. China Biologic Products Inc

9.3. Grifols Sa

9.4. Lfb Group

9.5. Csl Behring

9.6. Kedrion Biopharma

9.7. Octapharma AG

9.8. Takeda Pharmaceutical Company Limited

9.9. Bio Products Laboratory

9.10. Shanghai Raas Blood Products Co Ltd

9.11. Pfizer Inc

9.12. Sanquin Plasma Products Bv

9.13. Adma Biologics

9.14. Sichuan Yuanda Shuyang Pharmaceutical Co Ltd

9.15. Kamada Ltd

10. Research Methodology & Scope

For more information about this report visit https://www.researchandmarkets.com/r/41zw2p

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900